However, the presence of SOX1 antibodies was not confirmed with other techniques, a usual requirement in many ELISA assays, and the concentrations of SOX1 antibodies were significantly lower compared with those of controls that had PNS and SCLC, raising doubt on the clinical significance of the findings (10). The gene discussed is SOX1; the disease is paraneoplastic neurologic syndrome.